[HTML][HTML] Network pharmacology reveals that Berberine may function against Alzheimer's disease via the AKT signaling pathway
W Wei, J Yao, T Zhang, J Wen, Z Zhang… - Frontiers in …, 2023 - frontiersin.org
Objective To investigate the mechanism underlying the effects of berberine (BBR) in the
treatment of Alzheimer's disease (AD). Methods 3× Tg AD mice were treated with BBR for 3 …
treatment of Alzheimer's disease (AD). Methods 3× Tg AD mice were treated with BBR for 3 …
Network pharmacology‒based analysis of marine cyanobacteria derived bioactive compounds for application to Alzheimer's disease
In recent years, the Alzheimer's disease (AD) epidemic has become one of the largest global
healthcare crises. Besides, the available systemic therapies for AD are still inadequate. Due …
healthcare crises. Besides, the available systemic therapies for AD are still inadequate. Due …
[HTML][HTML] Network-based identification and mechanism exploration of active ingredients against Alzheimer's disease via targeting endoplasmic reticulum stress from …
Z Dai, T Hu, J Wei, X Wang, C Cai, Y Gu, Y Hu… - Computational and …, 2024 - Elsevier
Alzheimer's disease is a neurodegenerative disease that leads to dementia and poses a
serious threat to the health of the elderly. Traditional Chinese medicine (TCM) presents as a …
serious threat to the health of the elderly. Traditional Chinese medicine (TCM) presents as a …
CircPAN3/miR-221/PTEN axis and apoptosis in myocardial Infarction: Quercetin's regulatory effects
MM Farazi, F Rostamzadeh, S Jafarinejad-Farsangi… - Gene, 2024 - Elsevier
The circular RNA/microRNA/mRNA axis is a new layer of non-coding RNA-based regulatory
gene expression networks upstream of numerous cell signaling pathways. Circular RNA …
gene expression networks upstream of numerous cell signaling pathways. Circular RNA …